Skip to content

The Quality of Recovery From General Anesthesia With Desflurane for Fundus Surgery

Study on the Quality of Recovery From General Anesthesia With Desflurane for Fundus Surgery-A Single Center, Prospective, Randomized, Double-blind, Controlled Clinical Trial

Status
Not yet recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06241131
Enrollment
220
Registered
2024-02-05
Start date
2024-03-01
Completion date
2025-09-30
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Desflurane Anesthesia, Postoperative Recovery

Brief summary

The goal of this clinical trials to study and compare the effects of desflurane with remifentanil anesthesia (study group) and sevoflurane with remifentanil anesthesia (control group) for elective fundus surgery anesthesia. The main question it aims to answer are the characteristics of desflurane anesthesia in patients undergoing fundus surgery and to provide universal guidance for clinical application.

Interventions

The Desflurane was inhaled at a starting concentration of 1 MAC, and remifentanil 0.1 μg/kg/min was continuously pumped intravenously.

Sponsors

Sichuan Provincial People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. ASA I-II, patients aged 18-65 years old; 2. Fundus surgery to be performed under general anesthesia ; 3. The expected duration of surgery is about 30-120 min ; 4. BMI: 18-30 kg/m2 ; 5. Those who signed the informed consent form and volunteered to participate in this trial

Exclusion criteria

1. Patients with known or suspected genetic susceptibility to malignant hyperthermia; 2. Patients with history of asthma; 3. Patients with severe heart diseases (NYHA ≥ III, severe arrhythmia, etc.) and cerebral or pulmonary diseases, liver or kidney dysfunction; or with unstable vital signs; 4. Patients with history of long-term narcotic analgesics application, including sedative and antidepressant drugs; 5. Patients with history of psychotropic drug abuse within 3 months; 6. Patients with long-term alcohol abuse; 7. People with mental disorder and unable to communicate normally;

Design outcomes

Primary

MeasureTime frameDescription
Recovery timeup to 1 hourThe length of time from stopping anesthesia to patient recovery (opening eyes)

Contacts

Primary ContactZhang
giggle5707@163.com13882705707

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026